The most common translocation seen in patients with Multiple Myeloma is
**Core Concept**
Multiple Myeloma is a type of plasma cell malignancy characterized by the proliferation of malignant plasma cells in the bone marrow. Chromosomal translocations play a significant role in the pathogenesis of Multiple Myeloma, leading to the dysregulation of oncogenes and disruption of normal cellular function.
**Why the Correct Answer is Right**
The most common translocation in Multiple Myeloma involves the immunoglobulin heavy chain (IgH) locus on chromosome 14q32 and the cyclin D1 gene (CCND1) on chromosome 11q13. This translocation results in the overexpression of cyclin D1, leading to uncontrolled cell proliferation and tumor growth. The t(11;14)(q13;q32) translocation is detected in approximately 15-20% of Multiple Myeloma patients and is often associated with a favorable prognosis.
**Why Each Wrong Option is Incorrect**
* **Option A:** t(4;14)(p16;q32) is a less common translocation in Multiple Myeloma, involving the IgH locus and the fibroblast growth factor receptor 3 (FGFR3) gene or the MMSET gene. While it is associated with a poorer prognosis, it is not the most common translocation.
* **Option B:** t(14;16)(q32;q23) involves the IgH locus and the MAF gene, leading to the overexpression of the MAF transcription factor. This translocation is also less common and associated with a poorer prognosis.
* **Option D:** t(6;14)(p21;q32) involves the IgH locus and the cyclin D3 gene, leading to the overexpression of cyclin D3. While it is a rare translocation, it is not the most common one associated with Multiple Myeloma.
**Clinical Pearl / High-Yield Fact**
The detection of specific chromosomal translocations, such as t(11;14), can guide treatment decisions in Multiple Myeloma, including the use of targeted therapies and stem cell transplantation.
**Correct Answer: C. t(11;14)(q13;q32)**